Ironsides Asset Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ironsides Asset Advisors's LLY Position: Q2 2026 in Review
Ironsides Asset Advisors reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $25.5K and leaving 208 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #72.
Ironsides Asset Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $250K in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Ironsides Asset Advisors held 208 shares of Eli Lilly worth $249K as of Q2 2026.
- Ironsides Asset Advisors sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
- Eli Lilly made up 0.06% of Ironsides Asset Advisors's portfolio in Q2 2026, its #72 holding.
- Ironsides Asset Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- Ironsides Asset Advisors's Eli Lilly position peaked at $250K in Q4 2025.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Ironsides Asset Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.